CORC

浏览/检索结果: 共283条,第1-10条 帮助

限定条件                
已选(0)清除 条数/页:   排序方式:
Repressing MYC by targeting BET synergizes with selective inhibition of PI3K alpha against B cell lymphoma 期刊论文
CANCER LETTERS, 2022, 卷号: 524, 页码: 206-218
作者:  Chen, Zi-qi;  Cao, Zhe-rui;  Wang, Yi;  Zhang, Xi;  Xu, Lan
收藏  |  浏览/下载:53/0  |  提交时间:2021/12/16
CYH33  MYC  P300  BET  B cell lymphoma  PI3K  
Rhodomeroterpene alleviates macrophage infiltration and the inflammatory response in renal tissue to improve acute kidney injury 期刊论文
FASEB JOURNAL, 2021, 卷号: 35, 期号: 11, 页码: 17
作者:  Wu, Yong-Mei;  Shi, Qing;  Zhu, Peng-Fei;  Ma, Hai-Jian;  Cui, Shi-Chao
收藏  |  浏览/下载:54/0  |  提交时间:2021/12/16
Imatinib inhibits the malignancy of hepatocellular carcinoma by suppressing autophagy 期刊论文
EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 卷号: 906, 页码: 8
作者:  Xiao, Meng-Chao;  Qian, Hui;  Huang, Chen-Kai;  Zheng, Bai-Nan;  Yan, Fang-Zhi
收藏  |  浏览/下载:50/0  |  提交时间:2021/11/04
Discovery of thalidomide-based PROTAC small molecules as the highly efficient SHP2 degraders 期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 卷号: 218, 页码: 14
作者:  Yang, Xiangbo;  Wang, Zhijia;  Pei, Yuan;  Song, Ning;  Xu, Lei
收藏  |  浏览/下载:40/0  |  提交时间:2021/08/17
Anti-DLBCL efficacy of DCZ0825 in vitro and in vivo: involvement of the PI3K-AKT-mTOR/JNK pathway 期刊论文
ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2021, 卷号: 53, 期号: 5, 页码: 575-583
作者:  Hu, Ke;  Li, Bo;  Ma, Ruye;  Yi, Hongfei;  Xu, Zhijian
收藏  |  浏览/下载:68/0  |  提交时间:2021/06/11
Cytoplasmic DNA sensing by KU complex in aged CD4(+) T cell potentiates T cell activation and aging-related autoimmune inflammation 期刊论文
IMMUNITY, 2021, 卷号: 54, 期号: 4, 页码: 632-+
作者:  Wang, Yan;  Fu, Zunyun;  Li, Xutong;  Liang, Yinming;  Pei, Siyu
收藏  |  浏览/下载:61/0  |  提交时间:2021/06/11
Discovery of novel ceramide analogs with favorable pharmacokinetic properties and combination with AKT inhibitor against colon cancer 期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 卷号: 215, 页码: 13
作者:  Gao, Feng;  Chen, Xiaoxu;  Lu, Junyan;  Hu, Shulei;  Xu, Hui
收藏  |  浏览/下载:42/0  |  提交时间:2021/05/24
lncRNA H19 binds VGF and promotes pNEN progression via PI3K/AKT/CREB signaling (vol 26, pg 643, 2019) 期刊论文
ENDOCRINE-RELATED CANCER, 2021, 卷号: 28, 期号: 4, 页码: X1-X2
作者:  Ji, Meng;  Yao, Yanli;  Liu, Anan;  Shi, Ligang;  Chen, Danlei
收藏  |  浏览/下载:16/0  |  提交时间:2021/08/17
PI3K alpha inhibitor impairs AKT phosphorylation and synergizes with novel angiogenesis inhibitor AL3810 in human hepatocellular carcinoma 期刊论文
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 卷号: 6, 期号: 1, 页码: 3
作者:  Xie, Qin;  Chi, Shuaishuai;  Fang, Yanfen;  Sun, Yiming;  Meng, Linghua
收藏  |  浏览/下载:18/0  |  提交时间:2021/05/24
SAF-248, a novel PI3K delta-selective inhibitor, potently suppresses the growth of diffuse large B-cell lymphoma 期刊论文
ACTA PHARMACOLOGICA SINICA, 2021, 页码: 11
作者:  Zhang, Xi;  Duan, Yu-ting;  Wang, Yi;  Zhao, Xing-dong;  Sun, Yi-ming
收藏  |  浏览/下载:36/0  |  提交时间:2021/05/24


©版权所有 ©2017 CSpace - Powered by CSpace